MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
0.4060
+0.0295
+7.84%
Pre Market: 0.4000 -0.006 -1.48% 05:28 07/07 EDT
OPEN
0.3590
PREV CLOSE
0.3765
HIGH
0.4097
LOW
0.3518
VOLUME
835
TURNOVER
0
52 WEEK HIGH
3.440
52 WEEK LOW
0.3125
MARKET CAP
8.22M
P/E (TTM)
-0.2018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TRIB last week (0629-0703)?
Weekly Report · 1d ago
Trinity Biotech Clinical Data Validates CGM+ Advantage in Tackling False Low Glucose Alerts
TipRanks · 5d ago
Trinity Biotech Announces Clinical Study Results Showing Next-Gen CGM+ Wearable Biosensor Platform Delivers Purpose-Built Capability To Identify Nocturnal Compression-Related False Low Glucose Events
Benzinga · 5d ago
Trinity Biotech says clinical trial data show CGM+ detects nocturnal false low glucose readings
PUBT · 5d ago
Trinity Biotech says trial data show CGM+ detects nocturnal compression false lows
PUBT · 5d ago
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
Barchart · 5d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/30 21:05
Trinity Biotech’s Trinovium Joins Open Compute Project, Targeting Rapidly Growing AI Data Center Cooling Market
TipRanks · 06/30 13:38
More
About TRIB
Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

Webull offers Trinity Biotech PLC (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.